Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Global Market Study on Immunoassay Interference Blocker: ‘In Vitro’ Diagnostics Rapidly Advancing

Table of Content

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Market Trends
    1.3. Key Findings by Geography
    1.4. Analysis and Recommendations

2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations

3. Key Market Trends
    3.1. Competition Mapping

4. Key Success Factors
    4.1. Supply Chain Analysis
    4.2. Reimbursement Scenario

5. Global Immunoassay Interference Blocker Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
    5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
    5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
        5.2.1. Y-o-Y Growth Trend Analysis
        5.2.2. Absolute $ Opportunity Analysis

6. Global Immunoassay Interference Blocker Market – Pricing Analysis
    6.1. Regional Pricing Analysis, By Product Type
    6.2. Global Average Pricing Analysis Benchmark

7. Market Background
    7.1. Macro-Economic Factors
        7.1.1. Global GDP Growth Outlook
        7.1.2. Global R&D Expenditure Outlook
        7.1.3. Global Healthcare Industry Outlook
    7.2. Forecast Factors – Relevance & Impact
        7.2.1. Increase in R&D Funding and Grants
        7.2.2. Increase in Number of Patents Filed
        7.2.3. New Product Launches
        7.2.4. Investment by Venture Capitalists in Early Stage Biotech
    7.3. Market Dynamics
        7.3.1. Drivers
        7.3.2. Restraints
        7.3.3. Opportunity Analysis

8. Global Immunoassay Interference Blocker  Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type
    8.1. Introduction / Key Findings
    8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 – 2018
    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 – 2029
        8.3.1. Antibody Interference Blockers 
            8.3.1.1. Human Serum Derived Blockers
            8.3.1.2. Animal Serum Derived Blockers
            8.3.1.3. Human Immunoglobulin Blockers
            8.3.1.4. Animal Monoclonal Antibody IgG Blockers
            8.3.1.5. Animal Polyclonal Antibody IgG Blockers
            8.3.1.6. Heterophile Blocking Reagents
            8.3.1.7. Others
        8.3.2. Detection Interference Blockers
            8.3.2.1. Enzyme Blockers
            8.3.2.2. Alkaline Phosphatase Blockers
            8.3.2.3. β-Galactosidase Blockers
            8.3.2.4. Others
        8.3.3. Surface Interference Blockers
            8.3.3.1. Bovine Serum Albumin Blockers 
            8.3.3.2. BSA Fraction V blockers
            8.3.3.3. Poly BSA Blockers
            8.3.3.4. Solid Phase Blocking Buffers
            8.3.3.5. Polymeric Blockers
    8.4. Market Attractiveness Analysis By Product Type

9. Global Immunoassay Interference Blocker  Market Analysis 2014-2018 and Forecast 2019-2029, by Application
    9.1. Introduction / Key Findings
    9.2. Historical Market Size (US$ Mn) Analysis By Application, 2014 – 2018
    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2019 – 2029
        9.3.1. Sandwich Immunoassay
        9.3.2. Antibody Capture Assays
        9.3.3. Competitive ELISA
        9.3.4. Others
    9.4. Market Attractiveness Analysis By Application

10. Global Immunoassay Interference Blocker  Market Analysis 2014-2018 and Forecast 2019-2029, by End User
    10.1. Introduction / Key Findings
    10.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 – 2018
    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019 – 2029
        10.3.1. Academic & Research Institutes
        10.3.2. Biotechnology Companies
        10.3.3. Contract Research Organizations
        10.3.4. Molecular Diagnostics Companies
    10.4. Market Attractiveness Analysis By End User

11. Global Immunoassay Interference Blocker  Market Analysis 2014-2018 and Forecast 2019-2029, by Region
    11.1. Introduction
    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 – 2018
    11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029
        11.3.1. North America
        11.3.2. Latin America
        11.3.3. Europe
        11.3.4. East Asia
        11.3.5. South Asia
        11.3.6. Oceania
        11.3.7. Middle East and Africa (MEA)
    11.4. Market Attractiveness Analysis By Region

12. North America Immunoassay Interference Blocker  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029
    12.1. Introduction
    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018
    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
        12.3.1.  By Country
            12.3.1.1. U.S.
            12.3.1.2. Canada
        12.3.2. By Product Type
        12.3.3. By Application
        12.3.4. By End User
    12.4. Market Attractiveness Analysis
        12.4.1. By Country
        12.4.2. By Product Type
        12.4.3. By Application
        12.4.4. By End User
    12.5. Drivers and Restraints – Impact Analysis

13. Latin America Immunoassay Interference Blocker  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029
    13.1. Introduction
    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018
    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
        13.3.1.  By Country
            13.3.1.1. Brazil
            13.3.1.2. Mexico
            13.3.1.3. Rest of Latin America
        13.3.2. By Product Type
        13.3.3. By Application
        13.3.4. By End User
    13.4. Market Attractiveness Analysis
        13.4.1. By Country
        13.4.2. By Product Type
        13.4.3. By Application
        13.4.4. By End User
    13.5. Drivers and Restraints – Impact Analysis

14. Europe Immunoassay Interference Blocker  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029
    14.1. Introduction
    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018
    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
        14.3.1.  By Country
            14.3.1.1. Germany
            14.3.1.2. Italy
            14.3.1.3. France
            14.3.1.4. U.K.
            14.3.1.5. Spain
            14.3.1.6. BENELUX
            14.3.1.7. Russia
            14.3.1.8. Rest of Europe
        14.3.2. By Product Type
        14.3.3. By Application
        14.3.4. By End User
    14.4. Market Attractiveness Analysis
        14.4.1. By Country
        14.4.2. By Product Type
        14.4.3. By Application
        14.4.4. By End User
    14.5. Drivers and Restraints – Impact Analysis

15. South Asia Immunoassay Interference Blocker  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029
    15.1. Introduction
    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018
    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
        15.3.1.  By Country
            15.3.1.1. India
            15.3.1.2. Thailand
            15.3.1.3. Indonesia
            15.3.1.4. Malaysia
            15.3.1.5. Rest of South Asia
        15.3.2. By Product Type
        15.3.3. By Application
        15.3.4. By End User
    15.4. Market Attractiveness Analysis
        15.4.1. By Country
        15.4.2. By Product Type
        15.4.3. By Application
        15.4.4. By End User
    15.5. Drivers and Restraints – Impact Analysis

16. East Asia Immunoassay Interference Blocker  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029
    16.1. Introduction
    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018
    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
        16.3.1.  By Country
            16.3.1.1. China
            16.3.1.2. Japan
            16.3.1.3. South Korea
        16.3.2. By Product Type
        16.3.3. By Application
        16.3.4. By End User
    16.4. Market Attractiveness Analysis
        16.4.1. By Country
        16.4.2. By Product Type
        16.4.3. By Application
        16.4.4. By End User
    16.5. Drivers and Restraints – Impact Analysis

17. Oceania Immunoassay Interference Blocker  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029
    17.1. Introduction
    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018
    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
        17.3.1.  By Country
            17.3.1.1. Australia
            17.3.1.2. New Zealand
        17.3.2. By Product Type
        17.3.3. By Application
        17.3.4. By End User
    17.4. Market Attractiveness Analysis
        17.4.1. By Country
        17.4.2. By Product Type
        17.4.3. By Application
        17.4.4. By End User
    17.5. Drivers and Restraints – Impact Analysis

18. Middle East and Africa Immunoassay Interference Blocker  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029
    18.1. Introduction
    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018
    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
        18.3.1.  By Country
            18.3.1.1. GCC Countries
            18.3.1.2. Turkey
            18.3.1.3. Northern Africa
            18.3.1.4. South Africa
            18.3.1.5. Rest of Middle East and Africa
        18.3.2. By Product Type
        18.3.3. By Application
        18.3.4. By End User
    18.4. Market Attractiveness Analysis
        18.4.1. By Country
        18.4.2. By Product Type
        18.4.3. By Application
        18.4.4. By End User
    18.5. Drivers and Restraints – Impact Analysis

19. Emerging Countries Immunoassay Interference Blocker  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029
    19.1. Introduction
        19.1.1. Market Value Proportion Analysis, By Key Countries
        19.1.2. Global Vs. Country Growth Comparison
    19.2. China Immunoassay Interference Blocker  Market Analysis
        19.2.1. Introduction
        19.2.2. Market Value Proportion Analysis by Market Taxonomy
        19.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
            19.2.3.1. By Product Type
            19.2.3.2. By Application
            19.2.3.3. By End User
    19.3. India Immunoassay Interference Blocker  Market Analysis
        19.3.1. Introduction
        19.3.2. Market Value Proportion Analysis by Market Taxonomy
        19.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
            19.3.3.1. By Product Type
            19.3.3.2. By Application
            19.3.3.3. By End User
    19.4. Brazil Immunoassay Interference Blocker  Market Analysis
        19.4.1. Introduction
        19.4.2. Market Value Proportion Analysis by Market Taxonomy
        19.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
            19.4.3.1. By Product Type
            19.4.3.2. By Application
            19.4.3.3. By End User

20. Market Structure Analysis
    20.1. Market Analysis by Tier of Companies
    20.2. Market Share Analysis of Top Players
    20.3. Market Presence Analysis
        20.3.1. By Regional footprint of Players
        20.3.2. Product foot print by Players
        20.3.3. Channel Foot Print by Players

21. Competition Analysis
    21.1. Competition Dashboard
    21.2. Competition Deep Dive 
        21.2.1. Abcam plc
            21.2.1.1. Overview
            21.2.1.2. Product Portfolio
            21.2.1.3. Profitability by Market Segments (Product/Channel/Region)
            21.2.1.4. Sales Footprint
            21.2.1.5. Strategy Overview
                21.2.1.5.1. Marketing Strategy
                21.2.1.5.2. Product Strategy
                21.2.1.5.3. Channel Strategy
        21.2.2. AMS Biotechnology (Europe) Limited
            21.2.2.1. Overview
            21.2.2.2. Product Portfolio
            21.2.2.3. Profitability by Market Segments (Product/Channel/Region)
            21.2.2.4. Sales Footprint
            21.2.2.5. Strategy Overview
                21.2.2.5.1. Marketing Strategy
                21.2.2.5.2. Product Strategy
                21.2.2.5.3. Channel Strategy
        21.2.3. Aviva Systems Biology Corporation
            21.2.3.1. Overview
            21.2.3.2. Product Portfolio
            21.2.3.3. Profitability by Market Segments (Product/Channel/Region)
            21.2.3.4. Sales Footprint
            21.2.3.5. Strategy Overview
                21.2.3.5.1. Marketing Strategy
                21.2.3.5.2. Product Strategy
                21.2.3.5.3. Channel Strategy
        21.2.4. Bio-Rad Laboratories, Inc.
            21.2.4.1. Overview
            21.2.4.2. Product Portfolio
            21.2.4.3. Profitability by Market Segments (Product/Channel/Region)
            21.2.4.4. Sales Footprint
            21.2.4.5. Strategy Overview
                21.2.4.5.1. Marketing Strategy
                21.2.4.5.2. Product Strategy
                21.2.4.5.3. Channel Strategy
        21.2.5. Meridian Bioscience, Inc.
            21.2.5.1. Overview
            21.2.5.2. Product Portfolio
            21.2.5.3. Profitability by Market Segments (Product/Channel/Region)
            21.2.5.4. Sales Footprint
            21.2.5.5. Strategy Overview
                21.2.5.5.1. Marketing Strategy
                21.2.5.5.2. Product Strategy
                21.2.5.5.3. Channel Strategy
        21.2.6. Roche Diagnostics GmbH
            21.2.6.1. Overview
            21.2.6.2. Product Portfolio
            21.2.6.3. Profitability by Market Segments (Product/Channel/Region)
            21.2.6.4. Sales Footprint
            21.2.6.5. Strategy Overview
                21.2.6.5.1. Marketing Strategy
                21.2.6.5.2. Product Strategy
                21.2.6.5.3. Channel Strategy
        21.2.7. Rockland Immunochemicals, Inc.
            21.2.7.1. Overview
            21.2.7.2. Product Portfolio
            21.2.7.3. Profitability by Market Segments (Product/Channel/Region)
            21.2.7.4. Sales Footprint
            21.2.7.5. Strategy Overview
                21.2.7.5.1. Marketing Strategy
                21.2.7.5.2. Product Strategy
                21.2.7.5.3. Channel Strategy
        21.2.8. Scantibodies Laboratory, Inc.
            21.2.8.1. Overview
            21.2.8.2. Product Portfolio
            21.2.8.3. Profitability by Market Segments (Product/Channel/Region)
            21.2.8.4. Sales Footprint
            21.2.8.5. Strategy Overview
                21.2.8.5.1. Marketing Strategy
                21.2.8.5.2. Product Strategy
                21.2.8.5.3. Channel Strategy
        21.2.9. Thermo Fisher Scientific
            21.2.9.1. Overview
            21.2.9.2. Product Portfolio
            21.2.9.3. Profitability by Market Segments (Product/Channel/Region)
            21.2.9.4. Sales Footprint
            21.2.9.5. Strategy Overview
                21.2.9.5.1. Marketing Strategy
                21.2.9.5.2. Product Strategy
                21.2.9.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote